名称 | 銘柄コード | 市場 | 種別 |
---|---|---|---|
XTL Biopharmaceuticals Ltd | XTLB | NASDAQ | Depository Receipt |
始値 | 安値 | 高値 | 終値 | 前日終値 |
---|---|---|---|---|
2.49 | 2.48 | 2.7499 | 2.74 | 2.5698 |
最新ニュース
日付 | 時間 | ソース | タイトル |
---|---|---|---|
2024/7/23 | 05:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2024/6/13 | 05:05 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2024/6/05 | 22:20 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2024/6/05 | 22:15 | GLOBE | XTL Entered Definitive Agreement to Acquire The Social Proxy |
2024/5/13 | 23:32 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2024/3/20 | 23:15 | GLOBE | XTL To Aquire The Social Proxy |
2023/11/16 | 00:29 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2023/10/21 | 05:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2023/10/21 | 05:00 | GLOBE | XTL Biopharmaceuticals Confirms that it has not Experienced.. |
2023/8/10 | 22:30 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |